Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04073381 · ClinicalTrials.gov registry record · Early Phase 1
Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery
A Early Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 92
- Enrollment target
NCT04073381 is a Early Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 92 participants.
The verdict
NCT04073381, a Early Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will improve recovery and reduce perioperative complications via the proposed prehabilitation intervention.
Interventions
- COMBINATION_PRODUCT Prehabilitation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2018-10-28 |
| Est. Completion | 2020-08-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04073381
The ClinicalTrials.gov registry entry for NCT04073381 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prehabilitation Program is the first listed.
NCT04073381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04073381 about?
NCT04073381 is a clinical study titled "Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery". The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical patients with abdominal cancer. The investigators hypothesize that this prehabilitation program will ...
What is the current status of trial NCT04073381?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 92 participants. The study started on 2018-10-28. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT04073381?
The interventions under investigation include: Prehabilitation Program (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04073381?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.